Patients with SSc or Raynaud’s phenomenon exhibit increased vWF in plasma [126,127,128,129], an effect associated with disease severity [126], pulmonary involvement [127], and extent of ILD as determined by radiography [128]. This evidence concerns the gene VWF and systemic sclerosis.